Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Psych TopicsConsultation-liaison psychiatry

Psych · Consultation-liaison psychiatry

Renal and dialysis psychiatry

Also known as Dialysis psychiatry · CKD depression · ESRD mental health · Uraemic encephalopathy psychiatry · Haemodialysis anxiety · Renal consultation-liaison

Exam-exhaustive fellowship topic on renal and dialysis psychiatry for consultation-liaison practice — depression and anxiety in CKD/ESRD, CAST and ASCEND evidence, uraemic encephalopathy and cognitive impairment, psychotropic dosing and lithium–kidney interface, non-adherence, capacity and dialysis withdrawal, and shared nephrology–psychiatry care. FRANZCP-primary, globally tagged.

medium16 referencesUpdated 26 July 202612 min readVerification in progress

Practise this topic

  • 10 MCQs

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Uraemic encephalopathy (fluctuating confusion, asterixis, myoclonus, seizures) — urgent nephrology and dialysis optimisation; do not treat as primary psychosis alone
  • Active suicide plan, access self-harm, or deliberate life-threatening dialysis non-attendance — secure environment and joint nephrology–psychiatry plan
  • Lithium toxicity in CKD/AKI (coarse tremor, ataxia, confusion) — stop lithium, serial levels, volume support, escalate toward EXTRIP when criteria met
  • Request to stop dialysis with delirium or untreated severe depression — treat reversible drivers before accepting refusal as capacitous
  • Full-dose renally cleared psychotropics (lithium, amisulpride, paliperidone, gabapentinoids) without eGFR adjustment — accumulation risk
  • Intradialytic agitation with line-pulling — protect vascular access first, then de-escalate
On this page
Study tools

Your progress

Saved on this device.

Practise this topic10 MCQs with explanations

Target exams

FRANZCPMRCPsychABPNMD-DNBNEET-SS

Red flags

  • Uraemic encephalopathy (fluctuating confusion, asterixis, myoclonus, seizures) — urgent nephrology and dialysis optimisation; do not treat as primary psychosis alone
  • Active suicide plan, access self-harm, or deliberate life-threatening dialysis non-attendance — secure environment and joint nephrology–psychiatry plan
  • Lithium toxicity in CKD/AKI (coarse tremor, ataxia, confusion) — stop lithium, serial levels, volume support, escalate toward EXTRIP when criteria met
  • Request to stop dialysis with delirium or untreated severe depression — treat reversible drivers before accepting refusal as capacitous
  • Full-dose renally cleared psychotropics (lithium, amisulpride, paliperidone, gabapentinoids) without eGFR adjustment — accumulation risk
  • Intradialytic agitation with line-pulling — protect vascular access first, then de-escalate
The one-line answer

Renal and dialysis psychiatry is CL medicine at the kidney–brain interface: screen and treat depression and anxiety without nihilism; reverse uraemic and metabolic drivers of delirium and cognition; dose psychotropics to eGFR and dialysis timing; and separate an authentic capacitous dialysis withdrawal from depression, delirium, and coercion — co-managing with nephrology and palliative care.[1][4][5][6][11]

Meet the patient

A 64-year-old on maintenance haemodialysis is referred for "depression and non-compliance". She has missed her last two sessions, tells you life is not worth living, and her PHQ-9 came back at 19. The dialysis nurses add that she has been "vague and slow" mid-session this week.[1][7]

Two questions are live on this ward round, and the registrar will conflate them: is this depression, or uraemia, or both? and is she safe to drive home and to keep dialysing? A candidate who recites generic MDD criteria fails — the stem hides a medical differential, a dosing trap, a capacity question, and an adherence problem all at once.[4][5][11][13]

Psychiatry Fellowship Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Psychiatry Fellowship fellowship library.

Sign in to continueSee pricing
References16ShowHide
  1. [1]Palmer S, Vecchio M, Craig JC, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies Kidney Int, 2013.PMID 23486521
  2. [2]Palmer SC, Vecchio M, Craig JC, et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies Am J Kidney Dis, 2013.PMID 23623139
  3. [3]Hedayati SS, Minhajuddin AT, Toto RD, et al. Prevalence of major depressive episode in CKD Am J Kidney Dis, 2009.PMID 19493599
  4. [4]Hedayati SS, Yalamanchili V, Finkelstein FO A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease Kidney Int, 2012.PMID 22012131
  5. [5]Hedayati SS, Gregg LP, Carmody T, et al. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial JAMA, 2017.PMID 29101402
  6. [6]Mehrotra R, Cukor D, Unruh M, et al. Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial Ann Intern Med, 2019.PMID 30802897
  7. [7]Cukor D, Coplan J, Brown C, et al. Depression and anxiety in urban hemodialysis patients Clin J Am Soc Nephrol, 2007.PMID 17699455
  8. [8]Cukor D, Rosenthal DS, Jindal RM, et al. Depression is an important contributor to low medication adherence in hemodialyzed patients and transplant recipients. Kidney Int, 2009.PMID 19242502
  9. [9]Kimmel PL Depression in patients with chronic renal disease: what we know and what we need to know J Psychosom Res, 2002.PMID 12377308
  10. [10]Cohen SD, Cukor D, Kimmel PL Anxiety in Patients Treated with Hemodialysis Clin J Am Soc Nephrol, 2016.PMID 27660303
  11. [11]Cohen LM, Germain MJ, Poppel DM Practical considerations in dialysis withdrawal: "to have that option is a blessing" JAMA, 2003.PMID 12709469
  12. [12]Kurella M, Chertow GM, Luan J, et al. Cognitive impairment in chronic kidney disease J Am Geriatr Soc, 2004.PMID 15507063
  13. [13]Baghdady NT, Banik S, Swartz SA, et al. Psychotropic drugs and renal failure: translating the evidence for clinical practice Adv Ther, 2009.PMID 19444657
  14. [14]Nagler EV, Webster AC, Vanholder R, et al. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP) Nephrol Dial Transplant, 2012.PMID 22859791
  15. [15]McKnight RF, Adida M, Budge K, et al. Lithium toxicity profile: a systematic review and meta-analysis Lancet, 2012.PMID 22265699
  16. [16]Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup Clin J Am Soc Nephrol, 2015.PMID 25583292

Test yourself

Practise what you just read

  • 10 MCQs
Psychiatry Fellowship Pro

$29/ monthor $279 / year

The complete Psychiatry Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousPsycho-oncologyConsultation-liaison psychiatryNextSLE and autoimmune neuropsychiatryConsultation-liaison psychiatry